Not exact matches
«
In the long term, we want to be able to send energy to and communicate with implants all over the body, to record data from a variety of organs in many different ways, maybe even report on the conditions of tumors or cancer therapies,» Maharbiz say
In the long term, we want to be able to send energy to and communicate with implants all over the
body, to record data from a variety
of organs
in many different ways, maybe even report on the conditions of tumors or cancer therapies,» Maharbiz say
in many different ways, maybe even report on the conditions
of tumors or cancer therapies,» Maharbiz says.
Scientists have uncovered how
tumor cells
in aggressive uterine cancer can switch disguises and spread so quickly to other parts
of the
body.
The focus
of those hopes is the liquid biopsy: a test that could detect and analyze a solid
tumor from biomarkers
in the bloodstream or other easily sampled
body fluids, such as saliva.
Breast cancer
tumors can fuse with blood vessel cells, allowing clumps
of cancer cells to break away from the main
tumor and ride the bloodstream to other locations
in the
body, suggests preliminary research.
In the spring, the U.S. Food and Drug Administration approved an antibody that is the first cancer therapy based on a tumor genetic biomarker instead of a location in the bod
In the spring, the U.S. Food and Drug Administration approved an antibody that is the first cancer therapy based on a
tumor genetic biomarker instead
of a location
in the bod
in the
body.
When
tumor cells are present
in an environment that lacks oxygen and nutrients, they receive a signal that it is time for the cells to move to a different part
of the
body.
Once they have consumed all the oxygen and nutrients
in the original
tumor site, the cancer cells travel to other parts
of the
body (metastasize) to find more nourishment.
When the dendritic cells are activated, they train T cells — their allies
in the adaptive arm
of the immune system — to attack cancer cells anywhere
in the
body, whether at the site
of the original
tumor or distant metastases.
Previous work
in Weinberg's lab had shown that after a
tumor forms
in one part
of the
body, some
of the cancer cells undergo EMT, Mani explains.
It's this «immunosuppressive» microenvironment that gives the remaining
tumor cells license to metastasize and flourish
in other parts
of the
body.
Until the close
of the 19th century, a cancer patient had little choice but to watch
in terror as a
tumor hijacked his
body.
We found that the inflammation unfortunately gets hijacked by
tumor cells that are able to grow faster and penetrate deeper because the blood vessels
in the brain are more permeable than
in any other part
of the
body.
Tumors that originate in other organs of the body and spread to the brain are known as metastatic brain t
Tumors that originate
in other organs
of the
body and spread to the brain are known as metastatic brain
tumorstumors.
Pembrolizumab, or pembro, an immunotherapy drug that unmasks cancer cells and allows the
body's own immune system to help destroy
tumors, appears to be safe
in treating lung cancers, according to a study by Cancer Treatment Centers
of America ® (CTCA) at Western Regional Medical Center (Western)
in Goodyear, Arizona.
One advantage
of this method is that it only activates a certain type
of immune cell, the dendritic cell or T - cell, and only
in one part
of the
body, near the draining lymph nodes or
tumor, which helps cut down on the system - wide side effects often seen with chemotherapy.
Dr. Massagué is particularly interested
in the ability
of tumor cells to hug blood vessels, as he suspects this behavior may be essential for the survival
of metastatic cancer cells not only
in the brain but also
in other parts
of the
body where metastatic
tumor growth can occur.
Researchers at the University
of Leeds have made a new synthetic anti-cancer molecule that targets two key mechanisms
in the spread
of malignant
tumors through the
body.
When the scientists inserted human colorectal cancer cells into zebrafish embryos and allowed them to grow for 4 days, the resulting
tumors showed three hallmarks
of human solid
tumors: rapid cell division, formation
of blood vessels to supply nutrients, and the ability to spread to other locations
in the
body.
Although changes
in treatment methodology still have to be studied, Dr. Cripe believes it may be that the timing
of various treatments is what matters, and that perhaps initially suppressing immunity could allow the virus to infect a large number
of tumor cells before relieving the immunosuppression to allow the
body's own T cells to fight off the
tumor.
Conventional therapies target rapidly dividing
tumor cells, but are unable to eradicate the highly chemoresistant
tumor initiating cells (TICs), ultimately responsible for relapse and spreading
of the
tumors in other parts
of the
body.
Most
of the mutations that drive recurrent
tumors when they pop up elsewhere
in the
body were present
in the original
tumor, geneticist Elaine Mardis reported May 9 at the Biology
of Genomes meeting.
These broad categories simply refer to diverse
tumors that just happen to originate
in certain parts
of the
body.
Scientists now know that what matters most
in determining the behavior
of a particular cancer (and its response to specific therapy) are the molecular pathways that drive malignant cell growth instead
of where the
tumor begins
in the
body.
The mouse model could also contribute to the further development
of immunotherapies — a method
in which the
body's immune system is stimulated, so that it intensifies its fight against
tumor cells.
It is well established that melanoma cells can spread through the blood to accumulate and form new
tumors (metastases)
in other parts
of the
body away from the original
tumor.
The primary cause
of death from breast cancer is the spread
of tumor cells from the breast to other organs
in the
body.
«But mounting evidence confirming angiotropism and EVMM has revolutionized the knowledge
of how cancer spreads through the
body to the point that other scientists have confirmed the process
in other solid
tumor cell types such as pancreatic cancer.»
In a study presented in the featured clinical investigation article of the November issue of The Journal of Nuclear Medicine, they used 18F - fluorodeoxyglucose (FDG) PET / CT imaging to show that the amount of cell - free tumor DNA circulating in the bloodstream correlates with tumor metabolism (linked to cancer aggressiveness), not tumor burden (amount of cancer in the body
In a study presented
in the featured clinical investigation article of the November issue of The Journal of Nuclear Medicine, they used 18F - fluorodeoxyglucose (FDG) PET / CT imaging to show that the amount of cell - free tumor DNA circulating in the bloodstream correlates with tumor metabolism (linked to cancer aggressiveness), not tumor burden (amount of cancer in the body
in the featured clinical investigation article
of the November issue
of The Journal
of Nuclear Medicine, they used 18F - fluorodeoxyglucose (FDG) PET / CT imaging to show that the amount
of cell - free
tumor DNA circulating
in the bloodstream correlates with tumor metabolism (linked to cancer aggressiveness), not tumor burden (amount of cancer in the body
in the bloodstream correlates with
tumor metabolism (linked to cancer aggressiveness), not
tumor burden (amount
of cancer
in the body
in the
body).
In recent years a body of evidence has accumulated to show that chronic inflammation can play an important role in the progression of some types of tumors from a premalignant state to full - blown diseas
In recent years a
body of evidence has accumulated to show that chronic inflammation can play an important role
in the progression of some types of tumors from a premalignant state to full - blown diseas
in the progression
of some types
of tumors from a premalignant state to full - blown disease.
Understanding how cancer cells are able to metastasize — migrate from the primary
tumor to distant sites
in the
body — and developing therapies to inhibit this process are the focus
of many laboratories around the country.
Researchers at Rice University and the University
of Texas MD Anderson Cancer Center have refined and, for the first time, run
in vivo tests
of a method that may allow nanotube - based probes to locate specific
tumors in the
body.
The Mütter Museum
of medical anomalies at the venerable College
of Physicians
of Philadelphia is well supplied with helpful staff and airy colonnades, but what it could really use is a little stack
of printed leaflets explaining to the modern visitor how he or she is supposed to feel about all this, or at least what to make
of it: the uprooted genitalia and beach - ball
tumors, the skeleton
of the man whose muscle has turned to bone, the woman so fat that after death her
body transformed itself into soap, the embryos
in jars whose peeling labels break the sad but unsurprising news that not having a skull, or a brain, or a stomach, or any skin, is a state
of affairs «incompatible with life.»
Since XL184 is delivered to every part
of the
body and not just to the
tumor when administered orally, enclosing it
in the PMIL could reduce toxicity by confining its action to the area
of the
tumor.
For most available T cell immunotherapies, T cells (which play a central role
in defending the
body against illness) are engineered to recognize and eliminate
tumors, but their activity is not specifically controlled, leading to toxicity and unwanted side effects
in patients as a result
of inflammation or
in some cases suboptimal response to treatment.
In their study published in The Journal of Pathology, the team shows that tumor relapse occurs when the body, in effect, mobilizes itself in favor of the tumor, causing recurrence of the disease, increasing its aggressiveness and creating metastases or tumor sprea
In their study published
in The Journal of Pathology, the team shows that tumor relapse occurs when the body, in effect, mobilizes itself in favor of the tumor, causing recurrence of the disease, increasing its aggressiveness and creating metastases or tumor sprea
in The Journal
of Pathology, the team shows that
tumor relapse occurs when the
body,
in effect, mobilizes itself in favor of the tumor, causing recurrence of the disease, increasing its aggressiveness and creating metastases or tumor sprea
in effect, mobilizes itself
in favor of the tumor, causing recurrence of the disease, increasing its aggressiveness and creating metastases or tumor sprea
in favor
of the
tumor, causing recurrence
of the disease, increasing its aggressiveness and creating metastases or
tumor spread.
Metastasis (the spread
of cancer from its primary site to other places
in the
body) to the ovaries can result
in Krukenberg
tumors.
Only a few cells
in a cancerous
tumor are able to break away and spread to other parts
of the
body, but the curve along the edge
of the
tumor may play a large role
in activating these
tumor - seeding cells, according to a new University
of Illinois study.
Gartner's group plans to use the technique to investigate what cellular or structural changes
in mammary glands can lead to the breakdown
of tissue architecture associated with
tumors that metastasize, invading other parts
of the
body and threatening the life
of the patient.
Neurocutaneous disorders are caused by abnormal development
of cells
in the embryonic stage, leading to
tumors in various parts
of the
body, including the skin, organs, bones, brain and spinal cord.
Cancer researchers are just beginning to investigate the extent and significance
of genetic differences among
tumor cells — either cells within a discrete
tumor or between a primary
tumor and metastases
in other parts
of the
body.
To make the vaccine, researchers took a sample
of a patient's
tumors, which
in this trial were made up
of B cells (white blood cells that help the
body battle disease and infection).
For instance, a
tumor influences the expression
of genes
in immune system cells that are involved
in the
body's response to cancer.
Siva Vanapalli, an associate professor
in the Department
of Chemical Engineering, at Texas Tech University, recently received two grants from the Cancer Prevention and Research Institute
of Texas (CPRIT) to study the movement
of tumor cells throughout the
body and new methods
of detecting cancer cells.
Even if a
tumor has not metastasized, its effects extend far beyond the part
of the
body in which it is found.
Even a syringe
of one's own stem cells taken from one part
of the
body and squirted into another «may multiply, form
tumors, or may leave the site you put them
in and migrate somewhere else» the fda warns on its Web site.
IGRT is a common practice
in both photon (traditional radiation therapy) and proton therapy to treat
tumors close to sensitive structures and organs or
in areas
of the
body prone to movement or change
in shape.
In experiments with mice, the nanoparticle - based therapy not only wiped out the original targeted breast cancer tumors, but metastases in other parts of the body as wel
In experiments with mice, the nanoparticle - based therapy not only wiped out the original targeted breast cancer
tumors, but metastases
in other parts of the body as wel
in other parts
of the
body as well.
This method
of making larger superparamagnetic crystals paves the way for the development
of superparamagnetic bulk materials that can be reliably controlled by moderate external magnetic forces, revolutionizing drug delivery to
tumors and other sites
in the
body that need to be targeted precisely.
A doctor treating a patient with a potentially fatal metastatic breast
tumor would be very pleased to find, after administering a round
of treatment, that the primary
tumor had undergone a change
in character — from aggressive to static, and no longer shedding cells that can colonize distant organs
of the
body.
They showed that the iKnife could distinguish normal and
tumor tissues from different organs, such as breast, liver, and brain, and could even identify the origin
of a
tumor that was a metastasis, a secondary growth seeded by a primary
tumor elsewhere
in the
body.